ZOMDF — Zomedica Corp.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1684144 ·
Last close
$0.08
Market Cap
$78.40M
52W High
$0.16
52W Low
$0.06
ADV30
804,677
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 9,512,000 | 6,041,000 | -4,083,000 | -3,765,000 | 118,147,000 | 7,194,000 | 10,863,000 |
| Mar 2026 | 8,799,000 | 5,484,000 | -4,900,000 | -4,534,000 | 121,533,000 | 9,369,000 | 10,588,000 |
| Dec 2025 | 10,471,000 | 7,170,000 | -5,164,000 | -4,530,000 | 127,039,000 | 9,017,000 | 11,642,000 |
| Jun 2025 | 6,964,000 | 4,666,000 | -8,035,000 | -7,398,000 | 136,472,000 | 8,129,000 | 11,115,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,149,000
Investing CF
$13,136,000
Financing CF
$0
CapEx
$-1,731,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.08
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-308,072,000
Inventory
$6,050,000
Receivables
$6,025,000
ST Investments
$36,940,000
EBIT TTM
$-22,182,000
Pretax Income TTM
$-20,364,000
Interest Exp TTM
$0
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$36,877,000
EBITDA
$-13,203,000
Free Cash Flow
$-7,153,625
Enterprise Value
$39,204,312
Total Cash
$44,134,000
Total Debt
$1,831,000
Shares Out
979,949,668
Trailing EPS
$-0.02
Book Value
$0.11
ROE
-16.3%
ROA
-10.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 32,030,000 | -28,520,000 | -81,858,000 | 127,039,000 | 11,642,000 | 115,397,000 | -17,649,000 |
| Dec 2024 | 27,285,000 | -35,029,000 | -46,982,000 | 207,360,000 | 11,696,000 | 195,664,000 | -23,630,000 |
| Dec 2023 | 25,186,000 | -31,592,000 | -34,529,000 | 253,197,000 | 13,180,000 | 240,017,000 | -15,975,000 |
| Dec 2022 | 18,930,000 | -21,923,000 | -17,015,000 | 279,610,000 | 12,218,000 | 267,392,000 | -11,670,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LFVN | Lifevantage Corp | $78.42M | $6.26 | — |
| INCR | Intercure Ltd. | $78.17M | $5.21 | — |
| OSTX | OS Therapies Inc | $77.70M | $1.66 | — |
| GANX | Gain Therapeutics, Inc. | $77.69M | $1.78 | — |
| IBIO | iBio, Inc. | $76.53M | $1.19 | — |
News headlines (Yahoo Finance, 1h cache)
Zomedica Announces Strategic Partnership with Veterinary Study Groups (VMG) to Deliver Advanced Veterinary Technologies to Independent Practices
2026-09-22 10:00 · Yahoo
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
2026-08-13 10:00 · Yahoo
Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation
2026-08-11 10:00 · Yahoo
Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity
2026-08-05 20:15 · Yahoo
Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica’s Marketing Engine: How Demand Becomes Revenue
2026-09-09 10:00 · Yahoo
Zomedica Launches the PulseVet Acoustic Muffler(TM) Accessory for PulseVet(R) Shock Wave System
2026-08-04 10:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.